In the pharmaceutical and fine chemical industries, the quality of intermediates is non-negotiable. NINGBO INNO PHARMCHEM CO.,LTD., a dedicated supplier from China, places a strong emphasis on rigorous quality assurance for its product, 1-(4-Chlorobenzhydryl)piperazine (CAS: 303-26-4). This commitment ensures that our clients receive a product that not only meets but often exceeds industry standards for purity, consistency, and performance, making it an ideal choice for pharmaceutical grade synthesis and advanced research applications.

Our quality assurance process begins with meticulous control over the synthesis of 1-(4-Chlorobenzhydryl)piperazine. We employ advanced manufacturing techniques and adhere to strict protocols to minimize impurities and ensure a high assay value, typically greater than 98.0% by HPLC. Each batch undergoes comprehensive testing for critical parameters including appearance (off-white powder), solubility, and identification through methods like IR and HPLC. Detailed Certificates of Analysis (CoA) are provided, offering transparent documentation of the product's quality, which is essential for clients in regulated industries. This meticulous approach ensures that our 1-(4-Chlorobenzhydryl)piperazine is a reliable pharmaceutical intermediate, vital for the successful production of pharmaceuticals such as Cetirizine.

Furthermore, NINGBO INNO PHARMCHEM CO.,LTD. understands the importance of proper packaging and storage to maintain product integrity. 1-(4-Chlorobenzhydryl)piperazine is typically supplied in secure 25 kg drums, though custom packaging is available to meet specific customer requirements. Storing the product in a cool, ventilated place is recommended to preserve its quality over time. By prioritizing quality assurance at every stage, from manufacturing to delivery, we aim to be the preferred supplier for companies seeking dependable pharmaceutical intermediates and research chemicals. Our focus on providing high-quality piperazine derivatives supports the critical needs of global pharmaceutical and chemical research sectors.